Form 4: Annexon Executive Ted Yednock Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4
Ted Yednock, EVP & Chief Innovation Officer of Annexon, Inc., reports the acquisition of stock options and restricted stock units.
Summary
- On February 27, 2024, Ted Yednock acquired 44,963 restricted stock units (RSUs) of Annexon, Inc.
- These RSUs vest in three equal annual installments starting February 27, 2026.
- Yednock also acquired options to purchase 272,575 shares of Annexon's common stock at an exercise price of $2.50.
- These options vest monthly, starting February 27, 2025, over a four-year period.
- Following these transactions, Yednock directly owns 272,575 derivative securities and 106,200 shares of common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of stock options and RSUs can be seen as a positive sign of executive confidence, but it's a routine occurrence.
Positives
- The acquisition of RSUs and stock options suggests confidence in the company's future performance from a key executive.
- The vesting schedules for both RSUs and stock options incentivize long-term commitment from the executive.
Future Outlook
The vesting schedules suggest an expectation of continued employment and contribution from the executive over the next several years.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates compensation and incentives for a key executive at Annexon.
Comparison to Industry Standards
- Stock option and RSU grants are common compensation practices in the biotechnology industry to align executive interests with shareholder value.
- Vesting schedules are typical, with multi-year vesting periods encouraging long-term commitment.
- The specific terms of the grants (number of shares, exercise price, vesting schedule) would need to be compared to peer companies to assess their competitiveness.
Stakeholder Impact
- Shareholders may view the grant of stock options and RSUs as a way to align management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: acquisition of RSUs and stock options. |
| 02/27/2025 | Vesting Commencement Date for stock options; monthly vesting begins. |
| 02/27/2026 | First vesting date for 1/3rd of the RSUs. |
| 02/27/2034 | Expiration date of the stock options. |
| 03/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.